Exploiting Naturally Occurring Mutations to Engineer Next Generation T Cell Therapies 2022 Emerging Leader Award Jaehyuk Choi, MD, PhD, Northwestern University Read More
Molecular Mechanisms of Epigenetic Crosstalk between Histone Modifications and DNA Methylation in Cancer: New Avenues for Drug Development 2022 Emerging Leader Award Karim-Jean Armache, PhD, New York University Read More
Discovering the Mechanisms of Tumorigenesis by Driver Mutations Across Tissues 2022 ASPIRE Award Nuria Lopez-Bigas, PhD, IRB Barcelona (Spain) Read More
Bridging Predictive Models and Precision Immunotherapies 2022 ASPIRE II Award Benjamin Greenbaum, PhD, Memorial Sloan Kettering Cancer Center Read More
Deciphering Clonal Competition Between Oncogenic Mutant and Normal Cells And its Effect on Cancer Initiation 2021 Damon Runyon - Mark Foundation Postdoctoral Fellow Siqi Li, PhD, Fred Hutchinson Cancer Research Center Read More
The Role of Ribosomal Heterogeneity in T Cell Recognition of Tumor Cells 2021 ASPIRE Award Pia Kvistborg, PhD and William Faller, PhD, Netherlands Cancer Institute (NKI) (The Netherlands) Read More